Veterinary News,
Explained.

FDA approved generic nitenpyram tablets for treatment of flea infestations in dogs, puppies, cats, and kittens weighing at least two pounds and at least four weeks old. FDA states the tablets are bioequivalent to Capstar and work by interfering with the flea nervous system.

FDA approved KetoMed ketoprofen injectable solution for control of fever associated with bovine respiratory disease in several classes of cattle. FDA notes it is prescription-only and requires veterinary expertise to diagnose BRD and monitor safe use.

FDA announced its Third Annual Animal Drug User Fee Educational Conference for July 7, 2026, with topics including regulatory pathways, conditional approval, Minor Use/Minor Species, regulatory flexibility, animal biotechnology, protocol quality, and Q&A.

FDA issued an Emergency Use Authorization for Dectomax/Dectomax-CA1 (doramectin injection) for prevention and treatment of New World screwworm infestations in several livestock and cervid species.

FDA approved Tessie (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs, calling it the first approved treatment for both conditions in dogs.

FDA CVM announced FY 2026 grant funding for Animal and Veterinary Innovation Centers, long-term partnerships aimed at animal, human, or environmental health priorities.

FDA approved a generic moxidectin oral drench for treatment and control of internal parasites in sheep, including information on dosing and withdrawal restrictions.

FDA approved Amodip (amlodipine besylate chewable tablets) for control of systemic hypertension in cats, describing it as the first FDA-approved amlodipine product for veterinary use.

FDA announced May 27, 2026 public meetings and comment periods for reauthorization of ADUFA and AGDUFA, user-fee programs that support animal drug and generic drug review processes.

FDA issued an emergency use authorization for Negasunt Powder for prevention and treatment of New World screwworm myiasis in multiple livestock, equid, captive wildlife, exotic, and zoo mammal species, with specific safety and food-withdrawal requirements.

FDA announced approval of the first generic omeprazole oral paste for treatment of gastric ulcers in horses, adding a lower-cost option in an area many owners and equine practices already know well.

FDA approved the first generic injectable robenacoxib for postoperative pain and inflammation associated with certain surgeries in dogs and cats.

FDA added Prazi-Med, a praziquantel immersion powder for ornamental finfish, to the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species, creating a legal marketing pathway for a fish-parasite treatment through the indexing system rather than standard approval.